0000905148-24-000307.txt : 20240125
0000905148-24-000307.hdr.sgml : 20240125
20240125211711
ACCESSION NUMBER: 0000905148-24-000307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240123
FILED AS OF DATE: 20240125
DATE AS OF CHANGE: 20240125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Santos David A
CENTRAL INDEX KEY: 0001820066
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29889
FILM NUMBER: 24563916
MAIL ADDRESS:
STREET 1: RIGEL PHARMACEUTICALS, INC.
STREET 2: 1180 VETERANS BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001034842
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943248524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-624-1100
MAIL ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
X0508
4
2024-01-23
0001034842
RIGEL PHARMACEUTICALS INC
RIGL
0001820066
Santos David A
RIGEL PHARMACEUTICALS, INC.
611 GATEWAY BLVD, SUITE 900
SOUTH SAN FRANCISCO
CA
94080
true
EVP, Chief Commercial Officer
false
Common Stock
2024-01-23
4
A
0
209000
0
A
363612
D
Employee Stock Option (Right to Buy)
1.27
2024-01-23
4
A
0
157000
0
A
2034-01-23
Common Stock
157000
157000
D
The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025.
Includes 10,000 shares acquired under the Issuer's stock purchase plan.
The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period.
/s/ Raymond Furey (Attorney-in-Fact)
2024-01-25